GSK were alerted to counterfeit products by customers. On inspection of the packaging there was a number of inconsistencies between the authentic and fake packs the difference in the product however are more serious.
This is yet another counterfeit issue raised, surely this case and others demonstrate the size of the opportunities for the packaging industry to deliver smart and cost effective solutions.
FDA is warning consumers about counterfeit Alli reportedly sold over the Internet. Testing by manufacturer GlaxoSmithKline has revealed that the fake products contain the controlled substance sibutramine, not contain orlistat, the active ingredient in its product. FDA warns that this fake version of Alli 60 mg capsules (120 count refill kit) could be harmful if used improperly.
Via PPM News 20th January 2010. You can read the full article by clicking: http://bit.ly/5y3Pxy